Stefania Sartini

2.0k total citations
56 papers, 1.7k citations indexed

About

Stefania Sartini is a scholar working on Molecular Biology, Cell Biology and Organic Chemistry. According to data from OpenAlex, Stefania Sartini has authored 56 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 21 papers in Cell Biology and 16 papers in Organic Chemistry. Recurrent topics in Stefania Sartini's work include Aldose Reductase and Taurine (20 papers), Synthesis and biological activity (6 papers) and Biochemical effects in animals (6 papers). Stefania Sartini is often cited by papers focused on Aldose Reductase and Taurine (20 papers), Synthesis and biological activity (6 papers) and Biochemical effects in animals (6 papers). Stefania Sartini collaborates with scholars based in Italy, Germany and France. Stefania Sartini's co-authors include Concettina La Motta, Federico Da Settimo, Ettore Novellino, Luciana Marinelli, Sandro Cosconati, Sabrina Taliani, Francesca Simorini, Anna María Marini, Laura Mugnaini and Vito Coviello and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and PLoS ONE.

In The Last Decade

Stefania Sartini

56 papers receiving 1.7k citations

Peers

Countries citing papers authored by Stefania Sartini

Since Specialization

Citations

This map shows the geographic impact of Stefania Sartini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefania Sartini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefania Sartini more than expected).

Fields of papers citing papers by Stefania Sartini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefania Sartini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefania Sartini. The network helps show where Stefania Sartini may publish in the future.

Co-authorship network of co-authors of Stefania Sartini

This figure shows the co-authorship network connecting the top 25 collaborators of Stefania Sartini. A scholar is included among the top collaborators of Stefania Sartini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefania Sartini. Stefania Sartini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Oxy-imino saccharidic derivatives as a new structural class of aldose reductase inhibitors endowed with anti-oxidant activity 2020 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Felicia D’Andrea, Stefania Sartini, Ilaria Piano, (unknown), Luca Quattrini, Lorenzo Guazzelli, Lidia Ciccone, Elisabetta Orlandini, Claudia Gargini, Concettina La Motta, Susanna Nencetti	7
2	pH-Responsive Carboxymethylcellulose Nanoparticles for 68Ga-WBC Labeling in PET Imaging 2019 ·Polymers ·Anna Maria Piras, Angela Fabiano, Stefania Sartini, Ylenia Zambito, Simona Braccini, Emo Chiellini, (unknown), Francesco Bartoli, (unknown), Paola Anna Erba	10
3	Synthesis and investigation of polyhydroxylated pyrrolidine derivatives as novel chemotypes showing dual activity as glucosidase and aldose reductase inhibitors 2019 ·Bioorganic Chemistry ·Lorenzo Guazzelli, Felicia D’Andrea, Stefania Sartini, (unknown), (unknown), Luca Quattrini, Ilaria Piano, Susanna Nencetti, Elisabetta Orlandini, Claudia Gargini, Concettina La Motta	19
4	Chiral ionic liquids supported on natural sporopollenin microcapsules 2018 ·RSC Advances ·(unknown), Andrea Mezzetta, Lorenzo Guazzelli, Stefania Sartini, Christian Silvio Pomelli, Wallace O. Parker, Cinzia Chiappe	36
5	Acid Derivatives of Pyrazolo[1,5-a]pyrimidine as Aldose Reductase Differential Inhibitors 2018 ·Cell chemical biology ·Francesco Balestri, Luca Quattrini, Vito Coviello, Stefania Sartini, Federico Da Settimo, Mario Cappiello, Roberta Moschini, Antonella Del Corso, Umberto Mura, Concettina La Motta	18
6	Challenging clinically unresponsive medullary thyroid cancer: Discovery and pharmacological activity of novel RET inhibitors 2018 ·European Journal of Medicinal Chemistry ·Valeria La Pietra, Stefania Sartini, Lorenzo Botta, Alessandro Antonelli, Silvia Martina Ferrari, Poupak Fallahi, Alessio Moriconi, Vito Coviello, Luca Quattrini, Yi-Yu Ke, Hsing‐Pang Hsieh, Federico Da Settimo, Ettore Novellino, Concettina La Motta, Luciana Marinelli	15
7	Synthesis and Functional Evaluation of Novel Aldose Reductase Inhibitors Bearing a Spirobenzopyran Scaffold 2017 ·PubMed ·Maria Digiacomo, Stefania Sartini, Giulia Nesi, Simona Sestito, Vito Coviello, Concettina La Motta, Simona Rapposelli	4
8	N-(Aroyl)-N-(arylmethyloxy)-α-alanines: Selective inhibitors of aldose reductase 2017 ·Bioorganic & Medicinal Chemistry ·Susanna Nencetti, Concettina La Motta, Armando Rossello, Stefania Sartini, Elisa Nuti, Lidia Ciccone, Elisabetta Orlandini	15
9	FOXD1–ALDH1A3 Signaling Is a Determinant for the Self-Renewal and Tumorigenicity of Mesenchymal Glioma Stem Cells 2016 ·Cancer Research ·Peng Cheng, Jia Wang, Indrayani Waghmare, Stefania Sartini, Vito Coviello, Zhuo Zhang, Sung-Hak Kim, Ahmed Mohyeldin, Marat S. Pavlyukov, Mutsuko Minata, Claudia L.L. Valentim, Rishi Raj Chhipa, Krishna Bhat, Biplab Dasgupta, Concettina La Motta, Madhuri Kango‐Singh, Ichiro Nakano	117
10	1,2-Benzisothiazole Derivatives Bearing 4-, 5-, or 6-Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions 2016 ·Journal of Medicinal Chemistry ·Vito Coviello, (unknown), Stefania Sartini, Luca Quattrini, Anna María Marini, Francesca Simorini, Sabrina Taliani, Silvia Salerno, Paola Orlandi, Anna Fioravanti, Teresa Di Desidero, Daniela Vullo, Federico Da Settimo, Claudiu T. Supuran, Guido Bocci, Concettina La Motta	21
11	Nanostructured ultra-thin patches for ultrasound-modulated delivery of anti-restenotic drug 2015 ·International Journal of Nanomedicine ·Lorenzo Vannozzi, Leonardo Ricotti, Carlo Filippeschi, Stefania Sartini, Vito Coviello, Vincenzo Piazza, Pasqualantonio Pingue, Concettina La Motta, Paolo Dario, Arianna Menciassi	28
12	Pyrazolopyrimidine Derivatives as Antineoplastic Agents: with a Special Focus on Thyroid Cancer 2015 ·Mini-Reviews in Medicinal Chemistry ·Silvia Martina Ferrari, Concettina La Motta, Stefania Sartini, Enke Baldini, Gabriele Materazzi, (unknown), Ilaria Ruffilli, Salvatore Ulisse, Paolo Miccoli, Alessandro Antonelli, Poupak Fallahi	17
13	Synthesis, biological evaluation and docking analysis of a new series of methylsulfonyl and sulfamoyl acetamides and ethyl acetates as potent COX-2 inhibitors 2014 ·Bioorganic & Medicinal Chemistry ·Sara Consalvi, Salvatore Alfonso, Angela Di Capua, Giovanna Poce, (unknown), Manuela Sabatino, Rino Ragno, Maurizio Anzini, Stefania Sartini, Concettina La Motta, Lorenzo Di Cesare Mannelli, Carla Ghelardini, Mariangela Biava	23
14	CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo 2014 ·Molecular and Cellular Endocrinology ·Alessandro Antonelli, Guido Bocci, Concettina La Motta, Silvia Martina Ferrari, Poupak Fallahi, Alda Corrado, Anna Fioravanti, Stefania Sartini, Paola Orlandi, Simona Piaggi, Alessandro Corti, Gabriele Materazzi, David Galleri, Salvatore Ulisse, Gabriella Fontanini, Romano Danesi, Federico Da Settimo, Paolo Miccoli	19
15	Design, synthesis and biological evaluation of new classes of thieno[3,2-d]pyrimidinone and thieno[1,2,3]triazine as inhibitor of vascular endothelial growth factor receptor-2 (VEGFR-2) 2013 ·European Journal of Medicinal Chemistry ·Enrico Perspicace, Valérie Jouan–Hureaux, Rino Ragno, Flavio Ballante, Stefania Sartini, Concettina La Motta, Federico Da Settimo, Binbin Chen, Gilbert Kirsch, Serge Schneider, Béatrice Faivre, Stéphanie Hesse	51
16	A novel 2,3-diphenyl-4H-pyrido[1,2-a]pyrimidin-4-one derivative inhibits endothelial cell dysfunction and smooth muscle cell proliferation/activation 2013 ·European Journal of Medicinal Chemistry ·Serena Del Turco, Stefania Sartini, (unknown), Chiara Saponaro, Teresa Navarra, (unknown), Federico Da Settimo, Concettina La Motta, Giuseppina Basta	19
17	Sampling protein motion and solvent effect during ligand binding 2012 ·Proceedings of the National Academy of Sciences ·Vittorio Limongelli, Luciana Marinelli, Sandro Cosconati, Concettina La Motta, Stefania Sartini, Laura Mugnaini, Federico Da Settimo, Ettore Novellino, Michele Parrinello	96
18	Synthesis and Biological Evaluation of 2′‐Oxo‐2,3‐dihydro‐3′H‐ spiro[chromene‐4,5′‐[1,3]oxazolidin]‐3′yl]acetic Acid Derivatives as Aldose Reductase Inhibitors 2011 ·Archiv der Pharmazie ·Simona Rapposelli, Federico Da Settimo, Maria Digiacomo, Concettina La Motta, Annalina Lapucci, Stefania Sartini, (unknown)	21
19	Identification of 5-arylidene-4-thiazolidinone derivatives endowed with dual activity as aldose reductase inhibitors and antioxidant agents for the treatment of diabetic complications 2011 ·European Journal of Medicinal Chemistry ·Rosaria Ottanà, Rosanna Maccari, (unknown), Antonella Del Corso, Mario Cappiello, Umberto Mura, Sandro Cosconati, Luciana Marinelli, Ettore Novellino, Stefania Sartini, Concettina La Motta, Federico Da Settimo	95
20	Allosteric Modulators for Adenosine Receptors: An Alternative to the Orthosteric Ligands 2010 ·Current Topics in Medicinal Chemistry ·Concettina La Motta, Stefania Sartini, Micaela Morelli, Sabrina Taliani, Federico Da Settimo	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact